Topamax is a drug physicians prescribe for people with epileptic seizures and migraine headaches. Today the Food and Drug Administration posted a warning. Infants exposed to Topamax in the first trimester had a risk of developing cleft palate and/or cleft lip at a rate three times greater than those exposed to other anti-seizure medications. When an infant has cleft palate/cleft lip parts of the oral cavity do not fuse together. It is hard for the infant to eat and swallow. Poor feeding results in failure to gain weight, poor growth, increase risk of ear infections and other potential health risks. Treatment for this condition is surgery. Women who are pregnant or thinking of becoming pregnant should talk to their doctor if they are being treated with Topamax or their doctor suggests prescribing Topamax. For more information please see the FDA website: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncement/.